Zirex

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zirex

Zirex is a synthetic second-generation antihistamine used to relieve discomfort associated with allergic conditions. The drug's active component is Cetirizine Hydrochloride, which works systemically by blocking the action of histamine, the key chemical mediator of allergic symptoms.


Quick Facts

Property Description
Active ingredient Cetirizine Hydrochloride
Form Oral tablet, Oral solution, Oral syrup
Pharmacological class Second-generation H1-receptor antagonist
Common use Systemic relief of allergic symptoms
Origin Synthetic compound (Piperazine derivative)

What Type of Medicine is Zirex?

Zirex is a synthetic pharmaceutical drug classified as a second-generation antihistamine that belongs to the group of H1-receptor antagonists. This classification indicates its primary mechanism is to selectively inhibit the peripheral H1 receptors found on cells throughout the body. This class is characterized by its ability to neutralize the effects of histamine.

The medicine's active compound, Cetirizine Hydrochloride, is a carboxylic acid metabolite of Hydroxyzine, a first-generation antihistamine. This second-generation status is chemically associated with minimizing penetration into the brain, resulting in a reduced likelihood of adverse sedative effects compared to older antihistamines. This characteristic allows the medicine to effectively relieve allergy symptoms, such as seasonal hay fever or chronic hives, while minimizing disruption to cognitive function.


Composition and Available Pharmaceutical Forms

Zirex is a single active ingredient product, containing Cetirizine Hydrochloride as its sole active component. Chemically, Cetirizine is a piperazine derivative and a synthetic compound. The Zirex brand typically focuses its preparation on formulations suitable for both adults and pediatric patients.

For patient accessibility and ease of oral administration, the medicine is prepared in several pharmaceutical forms, including film-coated tablets, and the liquid preparations of oral solution and oral syrup. The availability of a liquid form is a differentiating factor, providing a convenient option for the pediatric patient group or individuals who have difficulty swallowing tablets. The active ingredient is combined with a stable base or excipient matrix to ensure the safe and effective delivery of the anti-allergic compound into the systemic circulation.

Regulatory References

  1. second-generation antihistamine
  2. Cetirizine Hydrochloride
  3. carboxylic acid metabolite
  4. reduced likelihood of adverse sedative effects
  5. StatPearls, NCBI Bookshelf

What side effects are possible with Zirex?

Possible Side Effects and Safety Information

The safety profile for Zirex (Cetirizine Hydrochloride) is officially documented by regulatory authorities, with adverse reactions classified by the frequency and organ system affected. The most frequently reported effects involve the Nervous System and General Disorders, though most are considered non-serious.


Frequency Classification of Adverse Reactions

Adverse reactions are grouped based on the standard regulatory frequency tiers, derived from clinical trials and post-marketing data:

  • Common (may affect up to 1 in 10 people): Reactions include somnolence (drowsiness), fatigue, headache, dizziness, dry mouth, and pharyngitis (sore throat). Somnolence has been noted in official labeling to be dose-related.
  • Uncommon (may affect up to 1 in 100 people): Less frequent reactions include paraesthesia (abnormal sensation), agitation, and general malaise or weakness.
  • Rare (may affect up to 1 in 1,000 people): Rare events may involve the immune system (hypersensitivity) and the cardiac system (tachycardia). Convulsions (seizures) and abnormal hepatic function have also been documented in this tier.
  • Very Rare (may affect up to 1 in 10,000 people): The most serious immune system effects, such as anaphylactic shock and angioneurotic oedema (swelling), are classified as very rare.

Population and Contextual Safety Constraints

Official safety documents include specific notes for certain patient conditions. Caution is noted for patients with predisposing factors for urinary retention. Also, the drug's elimination is prolonged in patients with renal impairment. The safety profile advises that concurrent use with alcohol or other CNS depressants may cause additional reduction in alertness. A specific safety pattern noted is the potential for severe pruritus (itching) upon discontinuation after long-term daily use.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes a Zirex overdose primarily by its effects on the Central Nervous System (CNS).

Documented Overdose Symptoms

The most common presentation of an overdose involves CNS depression, which can range from mild drowsiness and sedation to stupor or coma. Other signs may include slurred speech and ataxia (lack of voluntary muscle coordination).

In children, most symptoms appear within four hours of ingestion, with ataxia being the most commonly noted sign.

Risks and Emergency Action

While an overdose of Zirex alone typically causes a mild toxidrome of CNS depression with normal vital signs, the most severe, life-threatening risks—such as respiratory depression and airway compromise—are significantly increased if the drug is co-ingested with other substances, particularly ethanol (alcohol) or other CNS depressants.

Immediate Medical Help is Required

Seek immediate emergency medical attention (e.g., call 911 or Poison Control) for any suspected overdose. Emergency intervention is mandatory if symptoms include respiratory compromise or depression, or if the patient is in a stuporous or comatose state. Treatment is primarily supportive care, and any respiratory or abnormal vital signs must be addressed first, which may include measures for definitive airway management.

Therapeutic Uses of Zirex

Main Therapeutic Uses

Zirex is primarily indicated for the management of erectile dysfunction (ED) in adult men. This condition involves the persistent or recurrent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.

The medication belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors. It functions by supporting the physiological mechanisms that lead to an erection, specifically by enhancing the effects of nitric oxide, a natural chemical produced by the body that relaxes muscles in the penis to increase blood flow.

Benefits and Clinical Effects

The principal benefit of Zirex is the restoration of erectile function in response to sexual stimulation. Because the mechanism of action relies on the natural release of nitric oxide, the medication does not cause an erection in the absence of sexual arousal.

Improvement in Sexual Health Quality

Clinical applications of Zirex focus on several key outcomes:

  • Erection Maintenance: Assisting in the maintenance of an erection for a duration sufficient for completed sexual activity.
  • Response Reliability: Providing a more predictable physiological response to sexual stimuli for individuals with vascular or psychogenic ED.
  • Physical Confidence: Reducing the physiological barriers associated with erectile insufficiency, which may contribute to an improved sense of well-being regarding sexual health.

Mechanism of Action in Context

While Zirex addresses the physical symptoms of erectile dysfunction by improving blood flow, it is important to note that it is not a cure for the underlying causes of ED, such as cardiovascular disease or diabetes. It is used as a symptomatic treatment to facilitate the natural process of penile engorgement. The medication does not act as an aphrodisiac and does not increase sexual desire or libido.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for using Zirex (Cetirizine Hydrochloride) is determined by official regulatory bodies based on specific health conditions, age, and reproductive status.

Who Must Not Use Zirex (Contraindications)

Use of Zirex is contraindicated (absolutely prohibited) for individuals with a known hypersensitivity to the active ingredient, any of its components, hydroxyzine, or any piperazine derivatives. It is also contraindicated in patients with severe renal impairment (end-stage kidney disease) defined as a creatinine clearance less than 10 mL/min (EMA) or less than 15 mL/min (HPRA/some EU SmPCs).

Populations Requiring Conditional Eligibility

Population Group Eligibility Status (as per label)
Renal Impairment Requires dose adjustment for moderate to severe impairment ( CrCL le 50 mL/min) [Source 2.5].
Hepatic Impairment Conditional; dose adjustment is recommended if combined with renal impairment [Source 2.2].
Urinary Retention Risk Caution is recommended for patients with predisposing factors (e.g., prostatic hyperplasia) [Source 2.2].
Pregnancy Use only if the potential benefit justifies the potential risk to the fetus [Source 1.4].
Breastfeeding Use is generally not recommended due to excretion in human milk [Source 1.1, 1.4].
Children under 6 years Tablet formulations are not recommended as they do not permit necessary dose adaptation [Source 2.2]. Liquid forms may be used under a doctor's care for specific indications from 6 months of age [Source 1.3].

Official eligibility is structured around these exclusions and restrictions, defining the safe and permissible user base according to government regulators.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes officially documented interaction patterns for Zirex (Cetirizine Hydrochloride) as established in government regulatory sources, focusing on altered clearance and additive effects.

Pharmacodynamic and Substance Interactions

Co-administration with Alcohol and other Central Nervous System (CNS) Depressants is noted due to the risk of additive CNS depressant effects. This pharmacodynamic interaction may cause an additional reduction in alertness and further impairment of CNS performance, leading regulatory bodies to advise against concurrent use. Formal pharmacokinetic studies with Pseudoephedrine, Erythromycin, Ketoconazole, and Azithromycin found no clinically significant drug interactions.

Exposure-Altering and Contextual Interactions

Interacting Entity Interaction Type and Outcome
Theophylline (400 mg/day) Pharmacokinetic: Causes a 16% decrease in the clearance of cetirizine.
Food Pharmacokinetic: Does not affect the extent of absorption, but decreases the rate of absorption.
Renal or Hepatic Impairment Physiological: Leads to decreased drug clearance and increased systemic exposure.

Conclusion on Interaction Profile

The regulatory profile is structured around the need to avoid additive CNS impairment and includes a specific pharmacokinetic note regarding Theophylline. The clearance of Zirex is also significantly reduced in Geriatric Patients and those with Renal or Hepatic Impairment, requiring consideration due to increased systemic exposure.

Mechanism of Action

Zirex (cetirizine) functions as a selective antagonist of the peripheral histamine H1 receptor (H1).

The drug exhibits a high affinity for the H1 receptor, which is expressed on diverse cell types including respiratory smooth muscle, vascular endothelial cells, and immune cells. Zirex competitively binds to this receptor, preventing the binding and subsequent signaling cascade initiated by endogenous histamine.

Inhibition of the H1 receptor blocks the Gq protein-coupled receptor signaling pathway typically activated by histamine. This signaling normally leads to the stimulation of phospholipase C (PLC), which catalyzes the hydrolysis of PIP2 into the intracellular messengers IP3 and DAG. The resulting increase in intracellular calcium ion (Ca^2+) concentration and activation of protein kinase C (PKC) is prevented.

Downstream, Zirex modulates system-level physiology by inhibiting the histamine-mediated increase in capillary permeability and vasodilation in peripheral tissues. Furthermore, it exerts effects independent of H1 receptor antagonism by suppressing the NF-kappaB pathway and regulating the release of pro-inflammatory cytokines, which inhibits the chemotaxis and recruitment of inflammatory cells such as eosinophils and neutrophils to target tissues.

Dosage and Administration Information

How to Use Zirex: Official Administration Guidelines

Zirex is an oral tablet and must be swallowed whole without chewing or crushing. The official administration schedule involves a specific titration regimen starting with a loading dose and transitioning to a maintenance dose, with explicit rules regarding food intake.

Official Dosing Schedule

Dose Number Amount Frequency and Timing Food Requirement
Initial Dose (Dose 1) 100 mg Single dose Empty Stomach (1 hour before or 2 hours after food)
Subsequent Doses (2, 3, 4) 50 mg Every 12 hours (starting 12 hours after Dose 1) With or without food
Maintenance Doses (Dose 5 & after) 50 mg Every 24 hours (starting 12 hours after Dose 4) With or without food

Clear liquids (e.g., water, tea, black coffee) may be consumed during the empty-stomach window required for the initial 100 mg dose. It is required to avoid food or drink containing grapefruit throughout the treatment period.

Missed Dose Instructions

If one dose is missed, take the dose as soon as remembered and then resume the standard scheduled timing for the next dose. If two or more doses are missed, the official procedure is to take a 100 mg dose and then resume the next scheduled dose at the correct time. The use of Zirex has not been studied for longer than 14 days and should be used for the shortest duration consistent with treatment goals.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zirex

Evidence for Use in Seasonal and Perennial Allergic Rhinitis

Research examining Zirex in the context of allergic conditions, such as seasonal hay fever and year-round perennial rhinitis, has primarily relied on short-term, placebo-controlled Randomized Controlled Trials (RCTs). These studies included populations of adults, adolescents, and children. Research monitored patient-reported outcomes describing perceived discomfort, focusing on changes in symptom intensity or variability, such as scores related to nasal itching, sneezing, and ocular symptoms like watery eyes.

Studies reported measurements related to nasal and ocular symptom severity across the short follow-up periods. Studies reported patterns related to physical discomfort measured during the study period and outcomes reflecting daily functioning, often assessed using quality of life questionnaires. The core RCTs were predominantly short-term, typically lasting a few weeks, indicating that long-term outcomes for continuous, daily use are not well characterized. Comparative evidence against every available antihistamine is described as an evidence gap.


Evidence for Use in Chronic Idiopathic Urticaria (Chronic Hives)

Zirex was studied in the context of chronic idiopathic urticaria, a condition characterized by fluctuating or episodic manifestations of wheals (hives) and pronounced itching (pruritus). The evidence base includes controlled Randomized Controlled Trials (RCTs), where researchers examined changes in the severity of pruritus and wheals using validated scoring tools.

Research described patterns observed in the severity scoring of both itching and wheals during short- and intermediate-term observation periods. However, research highlights that findings were varied regarding the study outcome of maximum symptom suppression. Research provides limited data on outcomes beyond the three-month follow-up durations, and further data are still emerging.


What the Evidence Landscape Still Indicates as Uncertain

Follow-up durations were limited in many pivotal trials, meaning data for long-term outcomes and the long-term patterns of continuous use are not well characterized. Long-term effects are not fully established based on the core regulatory trial data, and certainty remains low in this area. Results apply only to the populations studied, and data for certain groups, such as the older adult population or specific comorbidity-defined groups, are still emerging.

Key Studies & References

  1. Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis
  2. Cetirizine: Uses, Interactions, Mechanism of Action (DrugBank Monograph)

Frequently Asked Questions (FAQ)

Common questions about Zirex (FAQ)

Q: Why do doctors often prescribe Zirex instead of older medications for the same issue?

Official product information classifies Zirex as a selective, second-generation antihistamine. This classification indicates that the drug is designed to work effectively against allergy symptoms. This characteristic is generally associated with a reduced potential for central nervous system effects when compared to older-generation antihistamines.

Q: Is Zirex effective for chronic conditions or only for short-term use?

Regulatory documents indicate that Zirex is approved for the relief of symptoms related to both temporary and chronic conditions. These indications include seasonal allergic rhinitis (a temporary condition) as well as chronic idiopathic urticaria (hives) and perennial allergic rhinitis (year-round allergies), which are long-term conditions.

Q: Do you need a prescription from a doctor to get Zirex?

In the United States, products containing the active ingredient found in Zirex, Cetirizine HCl, are generally available as an Over-the-Counter (OTC) Drug. Classification of the medication may vary by country.

Q: Are there different forms of Zirex (tablet, liquid, extended-release)?

According to official product labeling, the medication is available in several forms to suit different needs. These typically include oral tablets, liquid forms such as oral solutions or syrups, and liquid-filled capsules.

Q: Can Zirex be taken on an empty stomach or does it require food?

The maintenance doses of Zirex can generally be taken with or without food. The total amount of medication absorbed is not affected by food. However, official studies indicate that food may slow down how quickly the medicine is absorbed.

Q: What is the potential impact of Zirex on long-term cognitive function?

Official studies related to the drug's mechanism of action show that Zirex is designed to have negligible penetration into the brain. This mechanism of action is generally associated with a reduced likelihood of adverse central nervous system effects compared to first-generation antihistamines.

Q: What common over-the-counter cold medicines should be avoided while taking Zirex?

Regulatory warnings highlight the risk of an additive effect that may further reduce alertness if Zirex is used with other Central Nervous System (CNS) depressants, such as tranquilizers or sedatives. It is important to confirm whether any cold medicines contain substances that have CNS depressant effects.

Q: Is Zirex a controlled substance or has it been associated with dependency?

The active ingredient in Zirex, Cetirizine HCl, is not currently listed as a controlled substance by the US Drug Enforcement Administration (DEA) and is not known to be associated with drug dependency or abuse.

Q: Is Zirex known to interact with herbal supplements like St. John's Wort?

Official patient safety guidance suggests that individuals communicate the use of all medicines, vitamins, and herbal remedies to their healthcare provider. Comprehensive interaction data for every herbal supplement, including St. John's Wort, may not be available in the product label.

Q: Can Zirex affect one's ability to drive or operate machinery?

Official warnings state that Zirex may cause somnolence (drowsiness) or sedation. Due to this risk, the product labeling notes that individuals should use caution when performing activities that require mental alertness, such as driving or operating machinery. This risk is increased with the concurrent use of alcohol or other depressants.

Q: Are there any major food or drink restrictions when you're on Zirex?

Yes, official administration guidelines advise avoiding food or drink containing grapefruit throughout the entire course of treatment with Zirex. Additionally, clear liquids, such as water or tea, may be consumed during the empty-stomach window required for the initial dose.

Q: Does Zirex interact badly with common pain relievers like ibuprofen or Tylenol?

Formal pharmacokinetic studies found no clinically significant drug interactions with several medications. However, the label does not explicitly mention interactions with common pain relievers like ibuprofen or acetaminophen. Due to the lack of explicit data, it is important for individuals to communicate the use of all concurrent medications to a healthcare provider.

Q: Why do some people say Zirex gives them an upset stomach?

Official regulatory documents and clinical trials have reported adverse reactions that affect the gastrointestinal system. These include reports of nausea and abdominal pain among study participants, which can contribute to the feeling of an upset stomach.

Q: Is it normal to feel a bit dizzy when first starting Zirex?

Dizziness is listed as a common adverse reaction in clinical trials, meaning it may affect up to 1 in 10 people who take the medication. The official labeling indicates this as a general possibility, but it does not specify if the effect is more likely to occur only at the start of treatment.

Q: Does Zirex affect blood pressure or heart rate?

Zirex can be associated with certain cardiovascular effects, though they are reported infrequently. Tachycardia (an abnormally fast heart rate) is classified as a rare event based on data from clinical trials and post-marketing surveillance.

Q: Are there any known withdrawal symptoms when stopping Zirex?

Yes, official safety documents note a specific pattern upon stopping the medication. There is a potential for severe pruritus (intense itching) to occur when discontinuing Zirex after continuous, long-term daily use.

Q: Can Zirex be used safely during pregnancy or while breastfeeding?

For pregnancy, the labeling states that the medication should be used only if the potential benefit justifies the potential risk to the fetus. For breastfeeding, use is generally not recommended because the active ingredient is known to be excreted into human milk.

Q: Can taking Zirex cause changes in mood or sleep patterns?

Yes, adverse reactions reported in official documents include those affecting the central nervous system and mental state. These include changes such as somnolence (drowsiness) which is common, and feelings of agitation which are reported less commonly.

Q: Is Zirex safe to take alongside common vitamin supplements?

Official patient information suggests that individuals communicate the use of all vitamins, minerals, and supplements to a healthcare professional. This suggestion is made because the product labeling cannot account for interactions with every possible combination, and assessment is made on an individual basis.

How should Zirex be stored and disposed of?

How to Store and Dispose of Zirex

Official regulatory guidelines mandate specific conditions to maintain the stability and quality of Zirex (Cetirizine Hydrochloride).

Storage Requirements

  • Temperature: Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Liquid forms may specify storage not exceeding 30 C.
  • Protection: Keep the product in its original container and protected from light and moisture. Liquid formulations must not be frozen.
  • Child Safety: The medicine must be stored out of the sight and reach of children and pets.

Disposal Instructions

  • Unused or expired Zirex must be disposed of in accordance with local, regional, and national regulations. This typically requires following a medicine take-back program. The product should not be released into the environment (e.g., disposal down drains).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zirex found in:

A-Z Index: